Canada's patented medicine prices are among the highest in the world. Part of the problem is that the regulatory framework for Canada's quasi-judicial Patented Medicine Prices Review Board – which was established in 1987 – has "not been substantively updated since."
First, the government will add three additional measures to determine whether the cost of a drug is too high – including its financial impact on consumers. The government is also making a number of changes to the reporting requirements to help the board focus on medication that is at "greater risk of excessive pricing."
The move comes as the United States is facing ongoing media attention for the high cost of drugs, which has been driving consumers north to purchase medication. On July 31, the Trump administration also said it was considering putting in place a system that would allow Americans to purchase cheaper Canadian drugs legally, prompting concerns about Canada's drug supply.
You still never put in your header about with lower prices come no research. I guess the gov't has fairy dust to make new drugs.